Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients.
BACKGROUND
Coronary heart disease (CHD) and depression are two leading causes of death and disability in the United States and worldwide. Depression is especially common in cardiac patients, and there is growing evidence that depression is a risk factor for fatal and nonfatal events in CHD patients.


METHODS
This paper reviews current literature of depression as a risk factor for CHD along with pharmacologic and non-pharmacologic treatments for depression in cardiac patients.


RESULTS
Readers will gain knowledge about the importance of depression as a CHD risk factor and learn the results of efforts to treat depressed CHD patients.


CONCLUSIONS
Although randomized clinical trials (RCTs) of medication and non-pharmacologic therapies have not demonstrated that treating depression improves survival, there is evidence that treating depressed patients can reduce depressive symptoms and improve quality of life. Additional RCTs are needed, including evaluation of non-pharmacologic therapies such as exercise, to examine the effects of treatment of depression on medical and psychosocial outcomes.
Wang
Jenny T
JT
Duke University Medical Center, Department of Psychiatry and Behavioral Sciences, Box 3119, Durham, NC 27710, USA.
Hoffman
Benson
B
Blumenthal
James A
JA
D000928:Antidepressive Agents / Q000627:therapeutic use; D003327:Coronary Disease / Q000209:etiology*; D017281:Cost of Illness; D003863:Depression / Q000150:complications* / Q000188:drug therapy; D005081:Exercise Therapy; D005260:Female; D006801:Humans; D008297:Male; D012307:Risk Factors
D000928:Antidepressive Agents